Drug Topics

FEBRUARY 7, 2025

RBI-4000 is a self-replicating RNA (srRNA) vaccine developed to stimulate virus-neutralizing immune responses to rabies for prophylactic use.

Immunization 276

Immunization Vaccines 276

Drug Topics

MARCH 27, 2024

mRNA-1283 generated a stronger immune response against both the Omicron BA.4/BA.5 5 and the original virus strains of SARS-CoV-2 compared with Spikevax, Moderna’s licensed COVID-19 vaccine.

Vaccines 530

Vaccines Immunization 530

Drug Topics

AUGUST 30, 2022

This National Immunization Awareness Month, prepare your pharmacy to offer important vaccines.

Vaccines 469

Vaccines Immunization 469

Drug Topics

APRIL 24, 2024

In response to historically low flu vaccine coverage rates, Kristen Thorson, PharmD, urges pharmacists to think back to their pandemic immunization efforts and “know the power of their recommendation,” to boost public protection from influenza.

Vaccines 465

Vaccines Immunization 465

Drug Topics

OCTOBER 7, 2023

During a podcast hosted by Permanente Medicine, Sandra Fryhofer, MD, chair-elect of the Board of Trustees for the American Medical Association and a liaison to the CDC’s Advisory Committee on Immunization Practices, discussed the importance of vaccines for the fall and winter seasons.

Vaccines 491

Vaccines Immunization 491

Drug Topics

MAY 21, 2024

Research presented at DDW 2024 found there was no significant association between immune response and hepatitis B vaccine types in patients with Hepatitis C.

Immunization 281

Immunization Vaccines 281

Drug Topics

OCTOBER 3, 2024

Researchers suggest that vaccine champion programs could be a promising avenue to increasing immunization rates.

Vaccines 346

Vaccines Immunization 346

Drug Topics

MARCH 5, 2025

Researchers investigated the acceptability of community pharmacy-led influenza vaccination and patients willingness to return for future immunization.

Community Pharmacies 346

Community Pharmacies Vaccines Immunization 346

Drug Topics

APRIL 30, 2024

Recent research on COVID-19 vaccination shows that vaccines help fight variants, led to lower cases among children in California, and that boosters provide longer lasting protection.

Vaccines 281

Vaccines Immunization 281

Drug Topics

OCTOBER 2, 2023

Vaccines were tested against various strains of the SARS-CoV-2 virus.

Vaccines 281

Vaccines Immunization 281

STAT

MARCH 27, 2025

as the nation’s health secretary last month on the condition that Kennedy, a longtime vaccine critic, keep him apprised of agency actions, especially those related to vaccines.  Bill Cassidy, the chairman of the Senate health committee, voted to confirm Robert F. Kennedy Jr.    Read the rest…

Vaccines 141

Vaccines Immunization 141

Drug Topics

NOVEMBER 2, 2023

Vaccine manufacturers, including Novavax, are still hard at work updating immunizations against a mutating SARS-CoV-2 virus.

Vaccines 281

Vaccines Immunization 281

Pharmacy Times

MAY 12, 2025

A panelist discusses how physicians can navigate respiratory syncytial virus (RSV) vaccine selection by considering patient age, pregnancy status, and seasonality, highlighting the approved indications for Arexvy and Abrysvo, including maternal immunization to protect infants through passive immunity.

Vaccines 65

Vaccines Immunization 65

Drug Topics

JANUARY 8, 2024

Study authors noted that intranasal vaccine delivery could offer benefits such as needle-free administration and induction of mucosal immunity.

Vaccines 247

Vaccines Immunization 247

PhRMA

APRIL 28, 2025

As the United States confronts a resurgence of measles – a disease that was declared eliminated from the United States in 2000 through immunization – it’s a timely reminder of why vaccines remain one of the most powerful tools for preventing dangerous disease, protecting public health and reducing burden on the health care system. (..)

Immunization 144

Immunization Vaccines 144

STAT

JUNE 10, 2024

Moderna announced Monday that, in a Phase 3 clinical trial, its combination Covid-19 and influenza vaccine generated stronger immune responses in older adults than individual vaccines that target those viruses. Continue to STAT+ to read the full story…

Immunization 143

Immunization Vaccines 143

Pharmacy Times

AUGUST 23, 2022

Francesca Ceddia, MD, senior vice president of respiratory vaccines at Moderna, said the company is in early stages of development for a combined mRNA vaccine for influenza, COVID-19, and RSV.

Vaccines 177

Vaccines Immunization 177

Pharmacy Times

AUGUST 2, 2023

A panel of experts review the criteria used to select a specific high-dose flu vaccine formulation for immunization.

Immunization 123

Immunization Vaccines 123

STAT

FEBRUARY 28, 2024

has unveiled an advertising campaign aimed at boosting vaccination rates in children, which have steadily fallen over the past decade and took an even greater dip during the height of the Covid-19 pandemic. LONDON — Facing a growing outbreak of measles, the U.K. Read the rest…

Immunization 142

Immunization Vaccines 142

Pharmacy Times

DECEMBER 13, 2023

Fractional COVID-19 dosing resulted in fewer adverse effects and costs while producing similar immune responses compared to a full dose vaccine.

Immunization 139

Immunization Vaccines 139

Pharmacy Times

MAY 9, 2025

A recent study highlights the promising immune response and safety of the Arexvy vaccine in lung transplant recipients, crucial for preventing RSV infections.

Vaccines 65

Vaccines Immunization 65

Pharmacy Times

SEPTEMBER 25, 2023

For community pharmacists, cooler temperatures, school buses on the roads and Friday night football are not just signs of a changing season – they are indicators that patients will soon be seeking vaccinations for the 2023-2024 respiratory illness season.

Vaccines 148

Vaccines Immunization 148

Pharmacy Times

AUGUST 15, 2024

RSV and influenza vaccines demonstrated hemagglutination inhibition titers that were noninferior to those with sequential administration.

Vaccines 145

Vaccines Immunization 145

European Pharmaceutical Review

MARCH 6, 2023

The first clinical trial of any subunit tuberculosis (TB) vaccine in a temperature-stable form has found that ID93+GLA-SE, a freeze-dried vaccine, was safe. The recombinant subunit vaccine is made from four proteins of Mycobacterium tuberculosis bacteria combined with GLA-SE, an immune-stimulating adjuvant.

Immunization 103

Immunization Vaccines Communication 103

Pharmacy Times

DECEMBER 27, 2024

Individuals who refused a pneumococcal vaccine were associated with low collective responsibility and confidence in vaccine efficacy and safety.

Vaccines 132

Vaccines Immunization 132

European Pharmaceutical Review

JUNE 13, 2023

If approved, VLA1553 could become the first licensed chikungunya vaccine” A single vaccination of VLA1553 has been shown to produce neutralising antibody levels, thought to protect against chikungunya disease in 99 percent of Phase III trial participants. What did the chikungunya vaccine study results show?

Immunization 105

Immunization Vaccines 105

Pharmacy Times

NOVEMBER 14, 2022

Despite evidence of a higher risk of myocarditis or pericarditis with COVID-19 vaccination, immunization should still be recommended because the benefits likely outweigh the harms, study shows.

Vaccines 182

Vaccines Immunization 182

Pharmacy Times

AUGUST 3, 2022

Increasing population immunity decreased transmission of COVID-19 and allowed for reductions in quarantine and testing, encouraging 2-dose vaccine and booster uptake.

Immunization 123

Immunization Vaccines 123

Pharmacy Times

OCTOBER 28, 2022

Findings are encouraging for individuals with cancer who are receiving immune checkpoint inhibition treatment and want to get a third vaccine dose, investigators said.

Immunization 123

Immunization Vaccines 123

Pharmacy Times

OCTOBER 17, 2022

A researcher suggests that novel immune modulating cancer therapies like cancer vaccines can be more effective and safer alternative to previous cancer immunotherapies.

Vaccines 168

Vaccines Immunization 168

Pharmacy Times

MAY 24, 2023

Reporting vaccination data to Immunization Information Systems databases can support public health surveillance activities.

Immunization 121

Immunization Vaccines 121

Pharmacy Times

OCTOBER 13, 2022

Jeremy Graff, chief scientific officer at IMV, discusses why the development of viable cancer vaccines is a bit more slow-going in comparison to the fast-paced development of COVID-19 vaccines during the pandemic.

Vaccines 144

Vaccines Immunization 144

pharmaphorum

SEPTEMBER 7, 2020

A trial of Russia’s Sputnik V coronavirus vaccine has shown the jab produces an immune response, although the study was too small to produce conclusive findings, particularly on safety. The vaccine also produced a T-cell response within 28 days, a secondary outcome.

Immunization 107

Immunization Vaccines Hospitals 107

STAT

OCTOBER 25, 2023

Alison Buttenheim was floored by a sign she saw in her doctor’s office when she went to get the first jab of the two-dose shingles vaccine to protect her against painful flare-ups of varicella zoster. “Medicare patients cannot receive Tdap or zoster vaccines here. They need to obtain [them] at their pharmacy.

Vaccines 145

Vaccines Immunization 145

STAT

AUGUST 16, 2024

Pfizer and BioNTech said Friday that their combined mRNA vaccine candidate against influenza and Covid-19 showed a lower immune response against one type of influenza, influenza B, in a Phase 3 trial, a setback for the vaccine. ” Continue to STAT+ to read the full story…

Vaccines 139

Vaccines Immunization 139

Pharmacy Times

JANUARY 22, 2024

The schedule includes RSV vaccination, along with updated versions of the COVID-19 vaccine.

Vaccines 127

Vaccines Immunization 127

Pharmacy Times

OCTOBER 25, 2022

People with anxiety and related disorders were found to have vaccine hesitancy related to concerns regarding adverse effects and efficacy.

Vaccines 123

Vaccines Immunization 123